Category Archives: News

EQT Real Estate acquires I-78 Commerce Center, a recently developed logistics facility in Central Pennsylvania

eqt

20250912 DJI 0010 3

  • Single-asset acquisition of a newly built 809,000 square foot cross-dock distribution center in Berks Country, PA 
  • Facility is strategically located along Interstate 78, offering proximate access to nearly half of the U.S. population within a single day’s drive 
  • Transaction aligns with EQT Real Estate’s conviction in critical supply chain infrastructure and focus on high-spec assets in strategic U.S. distribution markets 

EQT Real Estate is pleased to announce that the EQT Real Estate Industrial Core-Plus Fund IV (“EQT Real Estate”) has acquired I-78 Commerce Center, a state-of-the-art cross-dock distribution center located in Berks County, Pennsylvania. 

Delivered in 2024, the facility features 40-foot clear heights, 590-foot building depth, and a 185-foot truck court, along with 123 dock-high doors, four drive-in doors, and parking for 156 trailers. Its cross-dock configuration and minimal office buildout are optimized for national distribution, and the site’s proximity to major Northeast distribution markets and the Port of New York and New Jersey supports same-day reach to nearly half of the U.S. population. 

The Pennsylvania I-78/I-81 corridor is one of the most competitive logistics markets in the country, with constrained industrial supply, prolonged entitlement timelines, and limited availability of large-format facilities. Positioned at the midpoint between the Northeast and Mid-Atlantic population centers, the property benefits from critical access to essential distribution infrastructure, including regional and international airports, considerable freight infrastructure and an intermodal rail terminal. 

Matthew Brodnik, Chief Investment Officer at EQT Real Estate, said: “This acquisition adds yet another high-quality asset to our logistics portfolio in one of the most supply-contrained and strategically located distribution markets in the U.S., with the facility’s design and location positioning it well to serve both regional and national demand. We remain focused on acquiring modern, mission-critical infrastructure that supports evolving supply chain needs, and this investment demonstrates our commitment to a long-term focus on access, scale, and tenant utility.” 

EQT Real Estate would like to thank Brad Ruppel, Michael Hines, Joseph Hill, and Brian Fiumara of CBRE National Partners, who represented the seller in the transaction.

Contact

EQT Press Office, press@eqtpartners.com

Downloads

About EQT Real Estate

EQT is a purpose-driven global investment organization with EUR 267 billion in total assets under management (EUR 139 billion in fee-generating assets under management) as of 30 September 2025, divided into two business segments: Private Capital and Real Assets. EQT supports its global portfolio companies and assets in achieving sustainable growth, operational excellence, and market leadership. Within EQT’s Real Assets segment, EQT Real Estate acquires, develops, leases, and manages logistics and residential properties in the Americas, Europe, and Asia. EQT Real Estate manages about $58 billion in GAV, owns and operates over 2,000 properties and 400 million square feet, with over 400 experienced professionals across 50 locations globally. 

More info: www.eqtgroup.com
Follow EQT Real Estate on LinkedIn

Categories: News

Tags:

Graphite + Cursor: One Engineering Platform for the AI Era

Accel

Today Graphite is joining forces with Cursor to build the ultimate engineering platform for the AI era.

When we first partnered with Merrill, Tomas, and Greg, we saw a massive opportunity to re-imagine code collaboration, starting with review. Code review’s core primitives had not been re-thought for decades, and the pressure on this “outer loop” was made obvious as AI increased code volume tenfold. Graphite was tackling these problems head-on with infrastructure that supported the fastest-moving engineering organizations at scale.

Similarly, our conviction in Cursor came from the belief that owning the core flywheel of code generation would be the richest source of intent and context for downstream workflows. We believed this “inner loop” would continue to compound, evolving from a mere text editor to an AI-native operating system engineers would live in every day.

Graphite + Cursor: One Engineering Platform for the AI Era

Fast forward to today, and these theses have converged. Code generation and review are rapidly blending together, and collaboration is becoming fluid across teams of humans and agents.

The refrain we now hear from engineering leaders is simple: the “inner loop” and “outer loop” should be connected.The ultimate software engineering platform will combine the raw horsepower of code generation with the reliability, contextual understanding, and collaboration of a code review platform. This combination is exactly what Graphite and Cursor make possible together.

From our time working with both teams, we see a lot of shared DNA: distinctive product taste, exceptional talent density across New York and San Francisco, and a relentless commitment to building tools developers absolutely love. Together, these qualities form a uniquely powerful foundation that is hard to replicate, and even harder to beat.

Congratulations to the entire Graphite team on this milestone. We couldn’t be more excited to continue to partner and build the platform to define engineering in the years to come.

written by

Christine Esserman

Categories: News

Tags:

Ardian signs an agreement to sell its stake in NHV to GD Helicopter Finance

No Comments
Ardian

Ardian, a global private investment firm, announces it has entered into exclusive discussions with GD Helicopter Finance (“GDHF”) to sell its majority stake in NHV, a leading European helicopter operator specializing in B2B services.

Founded in 1997 and headquartered in Ostend, Belgium, NHV has grown to become a leading B2B helicopter service provider, operating around the North Sea and West Africa. It has over 400 employees and operates a modern fleet of 28 aircraft, with a special focus on offshore transportation, including for the Oil & Gas and Maritime sectors. Its transportation services are complemented by maintenance, repair, overhaul and training activities.

Since its investment in NHV in 2013, Ardian has helped the company expand its historical offshore operations in Europe, notably as the launching customer of Airbus’ H175, one of the first “super-medium’ helicopters, but also via the acquisition of Blueway Group in 2014. In addition, it supported the Group’s diversification into MRO and training services, as well as expansion in the Defense sector. The company has demonstrated strong resilience over the past ten years in the context of wider market challenges, and has managed to return to a good organic growth trajectory and profitability. With Ardian’s support, Lars-Henrik Thorngreen has also been appointed as CEO one year ago, and promoted internal talents to its management team, who have demonstrated their ability to drive the company’s future growth.

The partnership with GDHF, a helicopter leasing and finance company based in Ireland, will combine GDHF’s large helicopter portfolio with NHV’s operational expertise to capture growing market opportunities, both in the group’s traditional sectors and in new segments.

“We are proud of our longstanding partnership with NHV and opportunities we have created together. The sale to GDHF demonstrates NHV’s strong strategic value and proven operational expertise in the sector. The company now is ideally positioned to capture growth potential in Europe and West Africa, in an industry with high barriers to entry. We would like to thank Lars-Henrick Thorngreen and the whole NHV team for their commitment throughout our collaboration and we wish NHV and GDHF every success for the future.” Anaïs Robin, Senior Investment Manager, Buyout, Ardian

“In the last ten years, NHV has been transformed to become a European leader in the B2B segment across a range of industries. Ardian’s operational expertise has been invaluable in helping us maintain cash generation, particularly through more difficult market conditions, and position the business for further development in the years to come. We are looking forward to the next steps of NHV’s growth story and to combining our strengths with GDHF to offer the best helicopter transportation services.” Lars-Henrik Thorngreen, CEO, NHV
The completion of the transaction remains subject to the usual regulatory approvals and customary closing conditions.

About Ardian

In a world of constant evolution, Ardian stands out for its ability to anticipate, adapt, and turn challenges into opportunities. As a global, diversified private markets firm with 22 offices and more than 350 investment professionals worldwide, we provide investment and customized solutions that reflect new economic dynamics and help our clients remain resilient in a changing world.
We deliver multi-local expertise and long-term performance for our investors and partners as well as shared value for the broader society. Since Ardian’s inception in 1996, our pioneering approach to diversification and our ability to offer tailor-made solutions at scale have remained the heart of our strategy.
Through commitment, knowledge and technology, we bring lasting value to our companies and contribute positively to the whole industry.
Ardian currently manages or advises $196bn for more than 1,890 clients worldwide across Private Equity, Real Assets, and Credit.
Ardian. Mastering change for lasting value.

ardian.com

About NHV

NHV Group, headquartered in Ostend Belgium, specialises in B-to-B helicopter services and operates with a strong geographic presence in Europe and Western Africa. The group conducts operations from several bases on two continents with a team of 450+ employees.
NHV’s main focus is on the energy-producing industry, including the Renewables Sector. The company’s scope of work also includes Maritime Services and Harbour Pilot Services, and Maintenance, Repair and Overhaul (MRO) solutions. In addition to supporting its own fleet, NHV provides extensive third-party maintenance services to a variety of civil and military clients. Aside from the helicopter operations, NHV has set up the NHV Training Academy, which offers ATO pilot training, HHOP training and delivers EASA and CAA certified Part 147 training. The group has a multipurpose high-value fleet of over 30 helicopters.

nhv.be

Press contact

HEADLAND

ardian@headlandconsultancy.com 

Categories: News

KKR acquires remaining stake in Wella from Coty

KKR
  • 750 million of immediate cash proceeds and right to significant share of ongoing proceeds after KKR preferred return
  • Marks successful completion of multi-year Wella monetization program exactly inline with its original target to divest Wella by end of CY25
  • Transaction reduces Coty’s financial net leverage to ~3x by the end of CY25, strengthening its path towards 2.0x

NEW YORK — (BUSINESS WIRE) — Regulatory News:

Coty Inc. (NYSE: COTY) (Paris: COTY) (“Coty” or “the Company”) today announced that it has sold its remaining 25.8% stake in Wella to KKR managed capital accounts and investment affiliates. Under the terms of the transaction, Coty will receive upfront cash consideration of $750 million and 45% of any proceeds from a further sale or an initial public offering of the business, after KKR’s preferred return has been met. Based on Wella’s strong recent and expected performance, as well as current market valuations, Coty sees strong potential for additional cash proceeds, bringing the total gross proceeds closer to the carrying value of its investment in Wella. The sale completes the program initiated in 2020 to simplify Coty’s portfolio and operations, while realizing the full value of its Wella business.

Coty intends to use the vast majority of the Wella upfront cash proceeds related to this transaction, net of tax, to pay down its short term and long term debt. Both the Wella proceeds and Coty’s strong free cash flow generation (over $350 million in the first half of FY26, inline with its recent guidance) are expected to reduce Coty’s financial net leverage to ~3x by the end of CY25.

“This transaction marks a pivotal milestone for Coty – both in our transformation and in our long-running deleveraging commitment,” said Laurent Mercier, Coty’s CFO. “Our strategic partnership with KKR has proven highly value accretive. We have benefited from Wella’s strong growth by progressively monetizing our stake, allowing us to strengthen Coty’s financial foundations year-after-year. Completing this transaction exactly inline with our original target to fully divest Wella by the end of CY25 underscores our focus on delivering on our financial commitments and crystallizing value from non-core assets, all while sharpening our strategic focus.”

Citi is serving as financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal advisor to Coty. Simpson Thacher & Bartlett LLP is serving as legal counsel to KKR.

About Coty Inc.

Founded in Paris in 1904, Coty is one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care. Coty serves consumers around the world, selling prestige and mass market products in over 120 countries and territories. Coty and our brands empower people to express themselves freely, creating their own visions of beauty; and we are committed to protecting the planet. Learn more at coty.com or on LinkedIn and Instagram.

Forward Looking Statements

Certain statements in this release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company’s current views with respect to, among other things, the use of proceeds from the sale transaction and the expected impact on Coty’s future results and financial condition as a result of the transaction including net debt and leverage ratio, as well as the extent and timing of any future profit distributions. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “are going to”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “temporary”, “target”, “aim”, “potential”, “goal” and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to the timing and cost of redemptions of the Company’s outstanding debt or other deleveraging activities, the timing and terms of any future Wella exit transaction by KKR and any related future profit distribution, and other factors described elsewhere in documents that the Company files with the SEC from time to time.

Contacts
For more information:

Investor Relations
Olga Levinzon, +1 212 389-7733
olga_levinzon@cotyinc.com

Media
Antonia Werther, +31 621 394495
antonia_werther@cotyinc.com

 

Download PDF

Categories: News

Tags:

HBox Receives Strategic Growth Investment from Charlesbank Technology Opportunities Fund

Charlesbank

Boston, MA – December 19, 2025: HBox (“HBox” or the “Company”), a leading virtual care platform for specialty practices, announced that it has received a growth investment from Charlesbank’s Technology Opportunities Fund (“TOF”) II. Amid rising chronic disease prevalence, expanding reimbursement for outcome-focused virtual care and innovative new ways for treating patients between visits, specialty practices are seeking scalable ways to extend treatment beyond the clinic. Charlesbank’s investment provides capital to help HBox advance key initiatives, including expanding its virtual care capabilities, furthering its mission to transform care delivery for patients with high-risk chronic conditions, and positioning itself as the virtual care partner to the specialty practice of the future. The transaction closed on December 17, 2025.

HBox is led by BanuPrasad Dhanakoti (Chief Executive Officer), Sandeep Subramanya (Chief Operating Officer) and Mohammed Ali (Chief Revenue Officer), who co-founded the Company. HBox delivers an integrated, AI-powered virtual care platform that leverages connected medical devices, next-generation patient-engagement tools and care services that create a virtual clinic within a clinic, enabling cardiology, pulmonology, nephrology and other specialty clinics to continue care seamlessly outside of in-person care settings. HBox aggregates real-time vitals, patient actions and clinical documentation into a unified system that allows physicians to efficiently manage large chronic populations while maintaining high-touch patient care.

“Today marks an important step forward for HBox and for the patients and clinicians we support,” said Banu Dhanakoti. “For cardiac patients in particular, timely monitoring and personalized care plans can help prevent hospitalizations and provide families with greater confidence in day-to-day condition management. With Charlesbank’s TOF team behind us, we can continue strengthening our offering and advancing a virtual care model that seeks to bring the cardiology clinic of the future into today’s specialty practices – enhancing quality and continuity of care without adding burden to clinics.”

Since its founding, HBox has delivered a fast pace of innovation and high service quality to customers, resulting in rapid customer growth and high patient compliance rates. Today, HBox is a mission-critical partner to independent specialty practices across the country.

“Preventative, virtual and continuous care is the future of healthcare for both improving outcomes and managing costs,” said Michael Zirngibl, Principal at Charlesbank. “We are excited to back Banu, Sandeep, Mo and the team as they continue to expand HBox’s innovative virtual ‘clinic within a clinic’ offering.”

“Remote monitoring and virtual care are becoming standard in many specialties, yet most practices lack the technology and staff to run these programs on their own,” added Hiren Mankodi, Co-Head of Charlesbank’s Technology Opportunities team. “HBox’s combination of software, services and specialty focus positions the Company to be that infrastructure at scale.”

Kaizen Equity Partners served as exclusive financial advisor to HBox, with K&L Gates serving as its counsel. Brown Gibbons Lang & Company served as financial advisor to Charlesbank, with Mintz and McDermott Will & Schulte as counsel.

Categories: News

Tags:

Bridgepoint Group launches its first private wealth offering

Bridgepoint
  • Marks the launch of the Group’s Private Wealth platform, with €200 million already raised and a mission to open access to the middle market for eligible individual investors.
  • Brings together a diversified portfolio of privately owned businesses in Europe and North America, enabling eligible investors to invest alongside Bridgepoint and Energy Capital Partners in sectors driving long-term economic growth.

 

Bridgepoint Group, one of the world’s leading mid-market investors, today announces the launch of its Private Wealth platform. With €200 million already raised, this marks a significant step in the Group’s ambition to provide access to private markets for eligible individual investors.

Overview

Both Bridgepoint Generations and Bridgepoint Generaciones provide eligible investors with the opportunity to invest directly alongside Bridgepoint in a diversified portfolio of privately owned mid-market businesses across Europe and North America.

The middle market has long been Bridgepoint’s home, a segment made up of companies substantial enough to shape economies yet agile enough to innovate and grow rapidly. Often founder- or family-led, these businesses are at pivotal points in their growth journey, offering compelling opportunities that have historically been difficult for individual investors to access.

The platform provides investors with access to the same opportunities as Bridgepoint’s institutional clients – including stakes in businesses such as Kyriba, a global leader in cloud-based liquidity management software; RoC Skincare, one of the largest independent skincare brands; PEI Group, a business intelligence company; and Meristem, one of the fastest-growing crop input companies in North America. Together, the products build on Bridgepoint’s 40-year track record of investing in high-quality, resilient companies that are shaping the global economy, offering exposure to long-term growth themes including energy transition, healthcare, advanced industrials, technology and services.

Bridgepoint Generations

Bridgepoint Generations is an open-ended strategy that combines investments from across Bridgepoint and Energy Capital Partners’ flagship funds in a single, diversified portfolio. It provides eligible investors with access to Bridgepoint’s private equity and energy transition strategies, including energy-transition projects developed through ECP. Once fully invested, the fund is expected to comprise approximately 80–100 companies and is fully funded from launch – unlike traditional closed-ended structures.

Bridgepoint Generations has been established in partnership with S64, with support from Simpson Thacher & Bartlett LLP and Arendt & Medernach SA as legal counsel, Carne Group as Alternative Investment Fund Manager, and Brown Brothers Harriman (BBH) as administrator and custodian.

Bridgepoint Generaciones

Launched in Spain, Bridgepoint Generaciones is a closed-ended fund focused exclusively on Bridgepoint’s European private equity strategies. Building on the Generations product, it combines the firm’s global scale, deep sector expertise and strong local presence to offer a tailored investment opportunity for eligible Spanish investors.

Once fully invested, the fund is expected to comprise approximately 30–40 European companies and has a three-year investment period.

As Bridgepoint’s first locally tailored investment product in Spain – a market where the firm has been investing for over 33 years, supporting and transforming leading companies such as Dorna Sports, Rovensa and Samy Alliance – the initiative underscores its long-term commitment to the region and ambition to extend its institutional capabilities to private wealth investors and intermediaries.

Bridgepoint Generaciones has been established in partnership with Amchor Investment Strategies, acting as Alternative Investment Fund Manager, with support from Simpson Thacher & Bartlett LLP as legal counsel.

Together, Bridgepoint Generations and Bridgepoint Generaciones represent a major step in the Group’s ambition to broaden access to private markets globally.

Speaking about the launch, Raoul Hughes, Chief Executive of Bridgepoint Group, said:

“For forty years we’ve been connecting great companies with the capital and expertise they need to grow. Through our private wealth offering, we’re opening that opportunity to more investors, bringing together our investment capabilities in a single platform that reflects the very best of what we do. This is about helping individuals invest alongside us in the companies shaping the world of tomorrow.”

Bridgepoint Group plans to expand its private wealth offering over time to include additional strategies such as credit, enabling eligible investors to access different parts of the risk-return spectrum.

Bridgepoint Group is one of the world’s leading quoted private asset growth investors, specialising in private equity, infrastructure and private credit.

With over $86 billion of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

Bridgepoint Advisers Limited, a subsidiary of Bridgepoint Group plc, is authorised and regulated by the Financial Conduct Authority.

Categories: News

Tags:

Bridgepoint Group adds Newbury Partners team to expand into fast-growing secondaries market and strengthen global alternatives platform

Bridgepoint
  • Bridgepoint adds a secondaries platform, expanding product offering and market reach
  • Highly experienced team enables Bridgepoint to capitalise on fast-growing secondaries market
  • Team expected to join in early 2026

 

Bridgepoint Group plc today announces it has agreed to add the team from Newbury, a leading mid-market secondaries investment firm with more than $4 billion of Assets under Management (“AUM”) as it continues to build a globally scaled, diversified alternatives platform. Upon satisfaction of customary closing conditions and conditions precedent, the experienced Newbury team is expected to join Bridgepoint in early 2026, expanding the Group’s capabilities into the attractive and fast-growing secondaries segment. The team brings established client relationships and, importantly, nearly two decades of proprietary data and performance history from the secondaries market, enhancing Bridgepoint’s analytical and investment capabilities.

Newbury specialises in acquiring limited partnership interests in established buyout, growth equity and venture capital funds. Founded in 2006, the team have raised over $6.5 billion in committed capital across six dedicated funds and have invested in more than 700 underlying private equity fund interests on behalf of over 250 limited partners worldwide, returning more than $5 billion in distributions since inception.

The team will manage Newbury’s most recent fund and will act as sub-advisor to its predecessor funds, adding $4.3bn of AUM to the Group at closing. In return for such sub-advisory services, Bridgepoint will receive an ongoing share of existing Newbury management fees making this a funded team lift.

Financial details are undisclosed.

Simpson Thacher & Bartlett LLP is serving as legal counsel and Campbell Lutyens as financial advisor to Bridgepoint. Latham & Watkins LLP is serving as legal counsel and Berkshire Global Advisors as financial advisor to Apollo in the transaction.

Raoul Hughes, Group Chief Executive of Bridgepoint, said:

“The addition of the Newbury team is a positive step in Bridgepoint’s evolution, as we continue to scale and diversify our platform. We have spent the past year evaluating the best route into secondaries, and the Newbury team brings proven expertise, strong relationships and an outstanding track record & data set which provides us with an attractive entry point from which to organically build a scaled platform.”

Chris Jaroch, Partner at Newbury Partners, added:

“We’re hugely excited to be joining Bridgepoint, a global leader in mid-market investing. With Bridgepoint’s strong brand and resources, combined with Newbury’s decades of experience in the secondaries space, we believe we can continue to build and scale a compelling, integrated platform for our investors.”

Bridgepoint Group is one of the world’s leading quoted private asset growth investors, specialising in private equity, infrastructure and private credit.

With over $86 billion of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

Bridgepoint Advisers Limited, a subsidiary of Bridgepoint Group plc, is authorised and regulated by the Financial Conduct Authority.

Categories: News

Tags:

CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries

5Am Ventures

Collaboration to leverage CAMP4’s RAP Platform® to accelerate development of novel antisense oligonucleotides (ASOs) for neurodegenerative and renal diseases

CAMP4 to receive $17.5 million upfront and eligible for additional milestone-based payments, in addition to tiered royalties

CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, has entered into a strategic research, collaboration and license agreement with GSK to identify and develop antisense oligonucleotide (ASO) drug candidates for multiple gene targets relevant to neurodegenerative and kidney disease indications.

“Protein under-expression plays a critical role in diseases such as neurodegenerative and kidney disease. Our collaboration with GSK, focused on the rapid identification of novel targets and potential ASO therapeutics that increase the expression of validated genetic targets, underscores the potential of our discovery platform to create transformational medicines for patients,” said Josh Mandel-Brehm, President and Chief Executive Officer of CAMP4.

Under the terms of the agreement, CAMP4 will receive a $17.5 million cash upfront payment. Additionally, CAMP4 has the potential to receive additional payments for certain development and commercial milestones, in addition to tiered royalties on future product sales.

CAMP4 will utilize its proprietary RAP Platform® to identify regRNAs controlling the expression of multiple gene targets and generate regRNA-targeting ASO candidates that amplify target gene expression for potential development. GSK will be responsible for the further development and commercialization of ASO drug candidates identified through the collaboration.

Chris Austin, SVP Research Technologies, GSK, said: “We are excited to collaborate with CAMP4, combining their RNA discovery platform to increase specific gene activity with GSK’s expertise in therapeutic oligonucleotides, genetics and advanced laboratory and data technologies. This agreement aims to drive the development of novel medicines for neurodegenerative and kidney disease and demonstrates our approach of harnessing cutting-edge technologies to deliver transformational therapies for patients.”

About CAMP4 Therapeutics 
CAMP4 is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein may offer therapeutic benefits. Our approach amplifies mRNA by harnessing a fundamental mechanism of how genes are controlled. To amplify mRNA, our therapeutic ASO drug candidates target regulatory RNAs (regRNAs), which act locally on transcription factors and are the master regulators of gene expression. CAMP4’s proprietary RAP Platform® enables the mapping of regRNAs and generation of therapeutic candidates designed to target the regRNAs associated with genes underlying haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200, in which a modest increase in protein expression may have the potential to be clinically meaningful. For more information, visit camp4tx.com.

Forward-Looking Statements 
This press release contains forward-looking statements which involve risks, uncertainties and contingencies, many of which are beyond the control of the Company, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning the development of ASO drug candidates for multiple gene targets relevant to neurodegenerative and kidney disease indications; the potential of the Company’s platform technology; the Company’s receipt of future contingent milestones and/or royalties; and the Company’s strategy, goals, business plans and focus. The forward-looking statements in this press release speak only as of the date of this press release and are subject to a number of known and unknown risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially from those anticipated in the forward-looking statements, including, but not limited to: the Company’s limited operating history, incurrence of substantial losses since the Company’s inception and anticipation of incurring substantial and increasing losses for the foreseeable future; the Company’s need for substantial additional financing to achieve the Company’s goals; the uncertainty of clinical development, which is lengthy and expensive, and characterized by uncertain outcomes, and risks related to additional costs or delays in completing, or failing to complete, the development and commercialization of product candidates; delays or difficulties in the enrollment and dosing of patients in clinical trials; the impact of any significant adverse events or undesirable side effects caused by product candidates; potential competition, including from large and specialty pharmaceutical and biotechnology companies; the Company’s ability to realize the benefits of the Company’s current or future collaborations or licensing arrangements and ability to successfully consummate future partnerships; the ability to obtain regulatory approval to commercialize any product candidate in the United States or any other jurisdiction, and the risk that any such approval may be for a more narrow indication; the Company’s dependence on the services of the Company’s senior management and other clinical and scientific personnel, and the Company’s ability to retain these individuals or recruit additional management or clinical and scientific personnel; the Company’s ability to grow the Company’s organization, and manage the Company’s growth and expansion of the Company’s operations; risks related to the manufacturing of product candidates, which is complex, and the risk that third-party manufacturers may encounter difficulties in production; the Company’s ability to obtain and maintain sufficient intellectual property protection for current and future product; the Company’s reliance on third parties to conduct preclinical studies and clinical trials; the Company’s compliance with the Company’s obligations under the licenses granted to the Company by others, for the rights to develop and commercialize the Company’s product candidates; risks related to the operations of suppliers; and other risks and uncertainties described in the section “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, as well as other information the Company files with the Securities and Exchange Commission. The forward-looking statements in this press release are inherently uncertain and are not guarantees of future events. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond the Company’s control, you should not unduly rely on these forward-looking statements. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual future results, levels of activity, performance and events and circumstances could differ materially from those projected in the forward-looking statements. Moreover, the Company operates in an evolving environment. New risks and uncertainties may emerge from time to time, and management cannot predict all risks and uncertainties. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. Except as required by applicable law, the Company does not undertake to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contacts

Investor Relations:
Sara Michelmore
Milestone Advisors
sara@milestone-advisorsllc.com

Media:
Jason Braco, Ph.D.
LifeSci Communications
jbraco@lifescicomms.com

Categories: News

Tags:

Empowering the Future of Energy: How exnaton is Leading Europe’s Electrification Shift

Elevator Ventures

Our portfolio company exnaton is driving electrification across Europe.

As Europe accelerates toward full-scale electrification, utilities are under increasing pressure to modernize their systems, launch innovative energy products, and meet rapidly evolving customer expectations. The rise of electric vehicles, rooftop solar and decentralized flexibility is transforming the energy market from a linear value chain into a dynamic ecosystem – one that demands smarter billing, transparent data andregulatory compliance at unprecedented scale.

Regulatory requirements are amplifying this shift. The EU Electricity Market Design law (Directive EU/2024/1711) has been transposed into national law, reshaping how Member States enable flexibility, consumer participation and dynamic pricing. This policy is underpinned by the continent-wide rollout of smart meters: Spain has reached 100% coverage, the Netherlands is above 95%, France is at 93%, and Austria has already surpassed roughly 95% of its meters by late 2024. Germany is targeting 95% by 2030 and Poland is moving toward 100% by 2031.

Utilities know change is unavoidable, and most recognize the challenge of moving fast enough in this new environment of electrification, flexibility and data-driven regulation.

This is where exnaton comes in.

A Real-World Challenge: Utilities Need Flexibility, not full IT Overhauls

Most utilities operate on legacy ERP systems built for a world of stable, predictable electricity flows. But dynamic tariffs, prosumer models, energy communities and smart electric vehicle charging require a more innovative approach to analyzing data coming from PoDs (Point of Delivery). The in-house development of capabilities, such as automated billing and seamless customer interfaces, is slow, expensive and often impractical.

Customers, meanwhile, increasingly expect transparency and personalization. Regulators demand accuracy and flexibility. Markets reward innovation.

exnaton bridges this gap with a modern intelligence layer that transforms existing infrastructure – without forcing utilities to rebuild it.

About exnaton: An Intelligence Platform Built for the New Energy System

Founded in Zurich in 2020, exnaton develops an AI-powered SaaS platform that helps utilities deploy next-generation energy products rapidly and at scale. Rather than replacing existing IT architecture, exnaton adds a modular, flexible intelligence layer that handles billingworkflows, dynamic pricing and data analysis.

Today, more than 50 utilities across Europe rely on exnaton’s technology – including examples such as TotalEnergies in Belgium, the E.ON brands eprimo, Bayernwerk in Germany, enersuisse in Switzerland, and Burgenland Energie in Austria – collectively demonstrating how exnaton enables both large multinational suppliers and regional champions to drive the digital transformation of the energy sector.

With research backgrounds from ETH Zürich, Stanford University, and University of St. Gallen, the team combines academic depth with practical industry expertise. Their mission is simple: empower utilities to deliver sustainable, data-driven energy products that make the energy transition tangible for every household.

Deep Dive: How the Platform Works – and why it matters

exnaton’s intelligence platform focuses onthree key areas that address the most pressing needs of today’s utilities:

AI-Enhanced Billing

Utilities can automate complex billing processes using granular, 15-minute energy data from smart meters. AI-powered processing ensures accuracy, reduces operational costs and minimizes manual reconciliation work – critical for dynamic tariffs and flexible grid fees.

Modular & Scalable Architecture

The platform integrates directly with existing ERP systems, enabling faster time-to-market for new, time-series-based energy products. Its modularity supports a wide range of use cases, from energy communities and peer-to-peer sharing to intelligent electric vehicle charging and prosumer billing.

White-Label Customer Experience

exnaton provides a customizable user interface that allows consumers to easily monitor their energy consumption, production and – where integrated – smart device activity. This transparency empowers customers to make data-driven decisions – and increases their engagement with sustainable products.

For utilities, this combination improves efficiency, unlocks new business models, and strengthens customer loyalty. For consumers, it makes the energy transition intuitive, accessible, and actionable.

Why Energy Tech: The “Beyond Banking” Trend

For Elevator Ventures, this is a crucial investment that aligns perfectly with our focus on “Beyond Banking” solutions in relevant areas like energy transition. The energy market represents a huge opportunity, particularly given Raiffeisen’s existing activities in the Austrian energy sector like Auri by Raiffeisenlandesbank Niederösterreich-Wien, Enlion and Raiffeisen Regenerative as well as the strong network of clients and partners in energy utilities across Austria and Central and Eastern Europe. As we see it, exnaton can play a leading role in the integration of finance into the future of energy.

Looking Ahead: Scaling Europe’s Decarbonized Grid

With its newly raised Series A financing, exnaton is poised to accelerate its European expansion and further develop AI-driven capabilities for real-time billing and decentralized and data-driven flexibility management.

Join us in Powering the Future

At Elevator Ventures, we believe in elevating the growth of founders who are building the infrastructure for tomorrow. By supporting exnaton, we are backing a team that is redefining how utilities innovate – and is ultimately accelerating the transition to a cleaner, smarterand more flexible energy system.

Learn more about exnaton: https://www.exnaton.ai/

picture of the exnaton software on phones

Categories: News

Tags:

IK Partners invests in Ascora

IK Partners

IK Partners (“IK”) is pleased to announce that the IK Small Cap IV Fund (“IK SC IV”) has acquired a majority stake in Ascora Group (“Ascora” or “the Group”), a French multi-specialist insurance broker, as part of a management buyout (“MBO”) designed to support its founder’s succession. IK has invested from its dedicated pool of Development Capital, with this transaction representing the fourth closed from IK SC IV, which held a final close on €2.0 billion in July 2025.

Founded in 1989 by Erik and Stéphane Henry, Ascora is one of the top 20 direct insurance brokers in France, offering end-to-end services from policy underwriting to claims management. Its expertise is organised across three main areas: Real Estate; Property & Casualty (“P&C”); and Health & Protection.

Largely operating in the Île-de-France region, Ascora serves over 12,000 clients. Grounded in technical depth and a people-centric culture built on proximity, trust and care, the Group has established a strong reputation for delivering highly personalised advice tailored to individual needs.

After more than three decades of leading the Group, Stéphane Henry wished to step back from his role as President. This transaction — led by IK with the support of both Stéphane and the management team — facilitates this transition and, as part of the MBO, enables the management team led by CEO Bruno Deschamps to increase its shareholding.

Ascora has successfully acquired 13 brokers to date and intends to continue executing a targeted buy-and-build strategy, leveraging IK’s Insurance Brokerage expertise built through its work with Yellow Hive (Netherlands), Ascentiel Group (France) and Seventeen Group (UK). Ascora also aims to strengthen its position as a leading insurance brokerage platform by accelerating growth in its core Real Estate and P&C segments, supported by investments in its sales team and digital tools. To ensure future scalability and effectiveness, it will look to further professionalise its central functions and strengthen its organisational structure.

Stéphane Henry, Founder of Ascora, said: “Over the past 30 years, we have focused on building a robust consolidation platform in the French insurance brokerage market and I am very proud of all that we have achieved together. As the Group enters the next phase of its journey with IK’s backing, I would like to thank everyone who has been instrumental in Ascora’s success to date and I look forward to supporting Bruno and the team in my new role on the Board.”

Bruno Deschamps, CEO of Ascora, added: “On behalf of the management team and everyone at Ascora, I would like to take this opportunity to thank Stéphane for his exceptional leadership over the past three decades. Our clients value the fact that we pick up the phone, fight their claims with the same determination we would apply to our own assets and provide genuine expertise — not just distribution. With IK as our partner, we will preserve everything that makes Ascora distinctive while expanding our presence and capabilities across France.”

Pierre Gallix, Managing Partner at IK and Advisor to the IK SC IV Fund, commented: “Ascora is a high-quality platform operating at the heart of resilient, high-growth real estate niches, supported by strong fundamentals such as recurring revenues, market-leading technical performance and an exceptionally skilled team. A hallmark of Ascora’s business model is its superior claims management capability, supported by a team of experienced legal professionals and in-house specialists. This approach has driven best-in-class loss ratios, high recovery rates and consistently strong outcomes for the Group’s clients. We are excited to partner with Bruno and his team on this next chapter and to accelerate the Group’s expansion through organic initiatives and bolt-on acquisitions.”

About Ascora

Founded in 1989 by Stéphane Henry, Ascora is one of the top 20 direct insurance brokers in France, offering end-to-end services from policy underwriting to claims management. Its expertise is organised across three main areas: Real Estate, Property & Casualty, and Health & Protection. For more information, please visit ascora.com

About IK Partners

IK Partners (“IK”) is a European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK. Since 1989, IK has raised more than €20 billion of capital and invested in over 200 European companies. IK supports companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit ikpartners.com

Read More 

Categories: News

Tags: